Search Results for: Agilis Biotherapeutics Announces First Patient
Articles
November 21, 2016
Agilis Biotherapeutics Announces First Patient Treated in Phase IIb Clinical Study November 21, 2016
Agilis Biotherapeutics recently announced that the first patient in the Phase IIb clinical study for its gene therapy treatment of...
October 31, 2019
Flexion Announces Clearance of NDA for Gene Therapy Candidate October 31, 2019
Flexion Therapeutics, Inc. recently announced clearance of the company’s Investigational New Drug (IND) application for FX201 in knee osteoarthritis.
